Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. HealthEast Institutional Review Board
483
•HealthEast Institutional Review Board•September 13, 2018

HealthEast Institutional Review Board – FDA 483, Sep 13, 2018

Record Details

During an inspection conducted from September 11-13, 2018, the Food and Drug Administration issued a Form 483 to HealthEast Institutional Review Board, identifying several significant observations related to its operational procedures and compliance. The inspection highlighted three primary areas of concern for the Saint Paul, MN-based IRB.

Firstly, the IRB was observed to lack and fail to follow adequate written procedures for the initial review of drug expanded access studies. Specifically, there were no defined requirements for submissions, and the IRB's file for a drug study lacked necessary FDA documentation, such as the Investigational New Drug (IND) application or approval letter.

Secondly, HealthEast IRB did not possess or adhere to written procedures for promptly reporting instances of serious or continuing noncompliance to the FDA. An internal recognition of serious noncompliance, involving the failure to report two serious adverse events for a study, was not communicated to the FDA, nor was the involved clinical investigator notified.

Finally, the inspection noted a failure by the IRB to notify an investigator after reclassifying a medical device study from non-significant to significant risk. This included a repeat observation regarding the IRB's failure to properly determine the risk level for an investigational medical device when a sponsor's Investigational Device Exemption (IDE) or risk determination was absent.

These observations indicate the need for HealthEast Institutional Review Board to develop and implement robust corrective actions to ensure its procedures align with regulatory requirements for protecting human subjects in research and accurately overseeing clinical investigations.

Company
HealthEast Institutional Review Board
Inspection date
September 13, 2018
Product type
devices
Office
Minneapolis District Office
People
  • Kellie L. Thommes (Consumer Safety Officer)
  • Dean R. Huska (IRB Chair)
View Company Profile

ID · 2beb9579-eadf-4a39-9703-8b521ba5acc6

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore HealthEast Institutional Review Board
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.